Required screening; facility requirements – Ohio Admin. Code 3701-55-02

All newborn children must be screened for the presence of the following genetic, endocrine, or metabolic disorders:

• Argininemia;
• Argininosuccinic acidemia;
• Biotinidase deficiency;
• Carnitine/acylcarnitine translocase deficiency;
• Carnitine palmitoyl transferase deficiency type II;
• Carnitine uptake defect;
• Citrullinemia;
• Congenital adrenal hyperplasia;
• Congenital hypothyroidism;
• Cystic fibrosis;
• Galactosemia;
• Glutaric acidemia type I;
• Glutaric acidemia type II;
• Homocystinuria (cystathionine-beta-synthase deficiency);
• Hypermethioninemia;
• Isobutyryl-CoA dehydrogenase deficiency;
• Isovaleric acidemia;
• Long chain hydroxyacyl-CoA dehydrogenase deficiency;
• Maple syrup urine disease;
• Medium chainacyl-CoA dehydrogenase deficiency;
• Methylmalonic acidemia;
• Multiple CoA carboxylase deficiency;
• Phenylketonuria;
• Propionic acidemia;
• Short chain acyl-CoA dehydrogenase deficiency;
• Trifunctional protein deficiency;
• Tyrosinemia type-I;
• Tyrosinemia type-II;
• Tyrosinemia type-III;
• Very long chain acyl-CoA dehydrogenase deficiency;
• 2-methylbutyryl-CoA dehyrogenase deficiency;
• 3-hydroxy-3-methylglutaryl-CoA lyase deficiency;
• 3-ketothiolase deficiency;
• 3-methylcrotonyl-CoA carboxylase deficiency; and
• Sickle cell and other hemoglobinopathies.